Table 2.
Use of medicines in Anatomical Therapeutic Classification (ATC) pharmacological groups A, C, and N.
| ATC Pharmacological Groups | N (%) | Mean Per Patient | |||
|---|---|---|---|---|---|
| A- ALIMENTARY TRACT AND METABOLISM | 119 (20) | 2.38 | |||
| A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 40 | ||||
| A02BA H2-receptor antagonists | 2 | ||||
| A02BC Proton pump inhibitors | 35 | ||||
| A10B Blood-glucose-lowering drugs, excl. insulins | 21 | ||||
| A10BA Biguanides | 8 | ||||
| A10BD Combinations of oral blood-glucose- lowering drugs | 5 | ||||
| C- CARDIOVASCULAR SYSTEM | 85 (15.0) | 1.7 | |||
| C03C High-ceiling diuretics | 27 | ||||
| C03CA Sulphonamides, plain | 16 | ||||
| C09D Angiotensin II receptor blockers (ARBs), combinations | 21 | ||||
| C09DA Angiotensin II receptor blockers (ARBs) and diuretics | 6 | ||||
| C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
6 | ||||
| C10A Lipid modifying agents, plain | 34 (16.7) | ||||
| C10AA HMG CoA reductase inhibitors | 21 | ||||
| N- NERVOUS SYSTEM | 59 (10.3) | 1.18 | |||
| N02B Other analgesics and antipyretics | 22 | ||||
| N02BA Salicylic acid and derivatives | 7 | ||||
| N02BE Anilides | 8 | ||||
| N05B–Anxiolytics | 23 | ||||
| N05BA Benzodiazepine derivatives | 19 | ||||